Candid Therapeutics Strikes Up Merger With Rallybio to Advance Its Autoimmune Drug Pipeline
Together with the reverse merger, Candid Therapeutics introduced $505 million in non-public financing to help its pipeline of T cell ...
Tag: pipeline
Boehringer Boosts Pipeline, Adding Oral Small Molecules With Broad Immunology & Inflammation Potential
Boehringer Ingelheim receives rights to oral small molecules from Sitryx with potential purposes in a number of autoimmune issues. Relying ...
Eli Lilly Boosts Its Immunology Drug Pipeline With $1.2B Ventyx Bio Acquisition
Eli Lilly is building its prospects in immunology through the $1.2 billion acquisition of Ventyx Biosciences, a clinical-stage company with ...
MuscleTech’s Quality Control Excellence and Innovation Pipeline with Raza Bashir
On Episode #183 of the PricePlow Podcast, Mike and Ben sit down with Raza Bashir, Chief Innovation Officer at MuscleTech ...
Sarepta Slashes Staff, Maps Path Forward for Gene Therapy and Narrower Pipeline
Sarepta Therapeutics’ report of a second fatality this year in a patient dosed with its Duchenne muscular dystrophy gene therapy ...
AbbVie’s $2.1B Acquisition Adds In Vivo Cell Therapy to Its Immunology & Inflammation Pipeline
AbbVie wasn’t part of the first wave of cell therapies developed for cancer, but it is positioning itself to contend ...
Recursion cuts nearly half of its pipeline
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your ...
CRISPR Biotech Caribou Trims Pipeline and Cuts 32% of Staff to Focus on Two Cancer Cell Therapies
Caribou Biosciences’ 2025 outlook aimed for key trial readouts for two cancer cell therapies in the first half of the ...
Astellas Exec Talks Dealmaking and Pipeline Strategy in Cancer, Gene Therapy & More
Cancer is well represented in the Astellas Pharma portfolio and pipeline, but the drugmaker has made diversification a key part ...
Lundbeck’s Neuro-Rare Pipeline Lands Cornerstone Drug via $2.6B Longboard Pharma Acquisition
Neuroscience drug developer Lundbeck is expanding its scope to epilepsy via the $2.6 billion acquisition of Longboard Pharmaceuticals, a company ...
Discover the latest in health and fitness with Your Health 247. Get expert advice, workout routines, healthy recipes, and mental wellness tips to lead a healthier, happier life. Stay informed and empowered with us!